A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.
This study has been terminated.
(Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.)
First Posted: March 6, 2008
Last Update Posted: December 1, 2011
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||June 2008|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|